Pharmaceutical

ImmunoGen and ImmunoBiochem partner for next-generation ADCs development

ImmunoGen has signed agreement with ImmunoBiochem for the development of next-generation antibody-drug conjugates (ADCs).

Jul 25, 2023 - 20:00
ImmunoGen and ImmunoBiochem partner for next-generation ADCs development
ImmunoGen has signed agreement with ImmunoBiochem for the development of next-generation antibody-drug conjugates (ADCs).
Read the original article

Tags:

Previous Article

Gilead and Cognizant expand deal to expedite digital transformation

Next Article

Private equity deals in pharmaceutical in Middle East and Africa increased in Q2...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Asian American doctors, overrepresented in medicine, are largely left out of leadership

Asian American doctors, overrepresented in medicine, ar...

Jul 26, 2023

STAT+: FDA approves Lilly ulcerative colitis treatment with a new approach to tamping down inflammation

STAT+: FDA approves Lilly ulcerative colitis treatment ...

Oct 26, 2023

Invenra’s antibody gains US FDA designations for neuroblastoma treatment

Invenra’s antibody gains US FDA designations for neurob...

Aug 27, 2024